Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation

Bone Marrow Transplantation

Volumn 19, Issue 4, 1997, Pages 385-387

  Maschan, A A ^a   Kryzanovskii, O I ^a   Yourlova, M I ^a   Skorobogatova, E V ^a   Pashanov, E D ^a   Potapova, Y E ^a   Timonova, L A ^a   Bogatcheva, N Y ^a   Samochatova, E V ^a   Roumjantzev, A G ^a  

^a Research Institute of Pediatric Hematology   (Russian Federation)

Author keywords

Bone marrow transplantation; Fanconi anemia; Myelodysplastic transformation

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; MERCAPTOPURINE; PREDNISOLONE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CONDITIONING; FANCONI ANEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0031050721     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700662     Document Type: Article

References (14)

1. Fanconi G. Familiäre infantile perniziosaartige Anäemie (perniziöses Blutbild and Konstitution). Jahrbuch Kinder 1927; 117: 257-268.
2. Butturini A, Gale RP, Verlander PC et al. Hematological abnormality in Fanconi anemia: an international Fanconi anemia registry study. Blood 1994; 84: 1650-1655.
3. Alter BP. Fanconi's anemia. Current concept. Am J Pediatr Hematol Oncol 1992; 14: 170-176.
4. Socié G, Gluckman E, Raynal B et al. Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction. Blood 1993; 82: 2249-2256.
5. Ikushima S, Hibi S, Todo S et al. Successful bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia. Bone Marrow Transplant 1995; 16: 621-624.
6. Auerbach AD. Fanconi anemia diagnosis and the diepoxibutane (DEB) test. Exp Hematol 1993; 21: 731-733.
7. Gluckman E, Hows J. Bone marrow transplantation in Fanconi's anemia. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific: Boston, 1994, pp 902-909.
8. Philpott NJ, Marsh JCW, Kumaran TO et al. Successful bone marrow transplant for Fanconi anaemia in transformation. Bone Marrow Transplant 1994; 14: 151-153.
9. Hirota T, Sekine I, Yamaoka K et al. Bone marrow transplantation for Fanconi anemia complicated with MDS. Jpn J Pediatr Hematol 1991; 5: 535-540.
10. Ratanatharathor V, Karanes C, Uberti J et al. Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndrome. Blood 1993; 81: 2194-2199.
11. Flowers MED, Doney KC, Storb R et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant 1992; 9: 167-173.
12. Deeg HJ, Socie G, Schoch G et al. Malignancies after marrow transplantion for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386-392.
13. De Witte T, Suciu S, Peetermans M et al. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). Leukemia 1995; 9: 1805-1811.
14. Young NS, Alter BP. Clinical features of Fanconi's anemia. In: Aplastic Anemia Acquired and Inherited. WB Saunders Co: Philadelphia, 1994, pp 275-309.